| Variables | Frequency (n) | Percentage (%) |
| Gender |
|
|
| Male | 27 | 41.5 |
| Female | 38 | 58.5 |
| Age group |
|
|
| 20 - 39 | 7 | 10.8 |
| 40 - 59 | 28 | 43.1 |
| ≥60 | 30 | 46.1 |
| Duration of HCV infection (in years) |
|
|
| 1 - 5 | 54 | 83.1 |
| 6 - 10 | 8 | 12.3 |
| 11 - 20 | 3 | 4.6 |
| Drug consumption |
|
|
| Traditional medicine | 12 | 6.1 |
| Modern medicine | 22 | 18.5 |
| Modern and traditional medicine | 4 | 33.8 |
| None | 27 | 41.6 |
| Alcohol consumption |
|
|
| Yes | 7 | 10.8 |
| At-risk | 4 | 6.1 |
| No | 58 | 89.2 |
| Body mass index |
|
|
| Normal | 27 | 41.5 |
| Overweight | 23 | 35.4 |
| Obesity | 15 | 23.1 |
| Genotype (n = 42) |
|
|
| 1 | 13 | 20.9 |
| 2 | 11 | 26.1 |
| 3 | 2 | 4.8 |
| 4 | 16 | 38.1 |
| Fibrosis staging (n = 50) |
|
|
| F0 | 9 | 18 |
| F1 | 11 | 22 |
| F2 | 9 | 18 |
| F3 | 5 | 10 |
| F4 | 16 | 32 |